世界保健機関 (WHO) の白血病のないアフリカのビジョン:機会と課題 - 物語の見直し
1Department of Biomedical and Laboratory Science, Africa University, Mutare, Zimbabwe.
Annals of medicine and surgery (2012)
|September 3, 2025
まとめ
アフリカの子供たちの白血病生存率は低く,ALLでは20%,AMLでは10%以下です. WHO を 達成 する
科学分野:
- 小児腫瘍学
- 世界保健
- アフリカ の 癌 予防
背景:
- 白血病はアフリカの子供の 罹病率と死亡率に大きな影響を及ぼします
- 診断が限られ,治療が遅い,財政的な障壁が治療を妨げています.
- 世界保健機関 (WHO) の児童がん対策グローバルイニシアチブ (GICC) は,2030年までに60%の生存率を達成することを目標としています.
研究 の 目的:
- WHOの世界的目標とアフリカ地域における白血病対策の調整を検討する.
- アフリカにおける白血病対策の進展,課題,機会をまとめます.
- 子どもの白血病の生存率を向上させるための戦略を特定する
主な方法:
- ネラティブ・レビュー・アプローチ
- ピアレビューされた文献,WHOの政策文書,地域保健戦略,灰色の文献 (2010-2024) の分析.
主要な成果:
- アフリカの多くの国で白血病の生存率は 世界的な目標には及ばない
- 急性リンパ性白血病 (ALL) の生存率はわずか20%であり,急性骨髄性白血病 (AML) の生存率はしばしば10%以下である.
- 現在の結果とWHOの2030年の生存目標の間に大きなギャップがあります.
結論:
- WHOが設定したアフリカにおける小児白血病の生存率の60%を達成することは可能ですが,緊急の行動が必要です.
- 主要な要件は,診断への投資,普遍的な健康保険への政治的コミットメント,統合されたがん対策計画です.
- 現地のイノベーションと地域特有の戦略の強化は,生存のギャップを埋め,回復力のあるケアシステムの構築に不可欠です.
さらに関連する動画
19:57An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
Published on: March 30, 2014
18.7K
09:57Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
Published on: March 5, 2018
29.6K
関連する概念動画
01:28International Nursing Organizations II
1.1K
The World Health Organization (WHO) is a specialized agency of the United Nations based in Geneva. The WHO has many initiatives that center around health. Primarily, they lead global efforts to expand universal health coverage using science-based policies and programs. They are also responsible for shaping health research agendas and developing norms and standards.
The WHO provides expert team support, including funding, vaccines, testing, and treatment tools at the country level to fight...
The WHO provides expert team support, including funding, vaccines, testing, and treatment tools at the country level to fight...
1.1K
02:49Cancer Therapies
7.9K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.9K
01:22Bone Marrow Sampling and Transplants
491
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
491
01:26Methods Of Healthcare Delivery System
3.5K
At the different levels of the healthcare system, we see varying methods of healthcare used. These methods include managed care systems, case management, and primary healthcare.
Managed Care System:
The managed care system is designed to control the cost while maintaining the quality of care. The patient's care from admission to discharge is planned by the primary care provider or the case manager, also known as the gatekeeper. In a managed care system, the number of care providers is...
Managed Care System:
The managed care system is designed to control the cost while maintaining the quality of care. The patient's care from admission to discharge is planned by the primary care provider or the case manager, also known as the gatekeeper. In a managed care system, the number of care providers is...
3.5K
02:56Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
01:27Disorders of Leukocytes
1.1K
Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
1.1K